Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
The inhibition of SIRP- CD47-SHP-1 axis by using CD47 antagonist, under clinical evaluation, leads to SnCs elimination and maintain the homeostasis of tissues
Malathion-induced granulosa cell apoptosis in caprine antral follicles: an ultrastructural and flow cytometric analysis
The mechanisms of ferroptosis Ferroptosis is a complex process regulated by various mechanisms
Fat quality shapes GLP-1 more than quantity
Effects of resistance exercise training on ADRD biomarkers For the last 2 decades, the discourse related to the underlying mechanism for development of AD specifically has largely focused on the amyloid hypothesis, attributing the transition from MCI to AD to the accelerated rate of A plaque deposition and subsequent neurofibrillary tangle formation (Hardy and Higgins, 1992)